Drug intelligence / Profile preview

BLISS Mints

Development stage
Unknown
Lead developer
BOHECO
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Sublingual
01

Overview

BLISS Mints are a cannabis-based, prescription-grade sublingual Ayurvedic formulation developed by BOHECO (Bombay Hemp Company) to support focus, mental clarity, and manage mild anxiety and everyday stress. Each mint contains 20 mg of cannabidiol (CBD) derived from naturally grown *Cannabis sativa* (Vijaya) leaf extract, combined with traditional Ayurvedic adaptogens and calming botanicals including Ashwagandha (*Withania somnifera*), Brahmi (*Bacopa monnieri*), Tulsi (*Ocimum sanctum*), Chamomile (*Matricaria chamomilla*), and Lavender (*Lavandula angustifolia*). The formulation is designed to interact with the body's endocannabinoid system (ECS) via CB1 and CB2 receptors to regulate the stress response and promote emotional balance without causing intoxication or euphoria.

Brand names
BLISS Mints
Other names
BLISS Phytogenic CBD MintsBoheco BLISS Mints
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on BLISS Mints.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BLISS Mints.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call